Recursion Pharmaceuticals RXRX announced that it has dosed the first patient in its early-stage study of investigational ...

SGN-CD19A demonstrated anti-tumor activity across a panel of cell lines derived from multiple B-cell lymphoma and leukemia ... that define the 'ideal' ADC and mechanisms of ADC resistance require ...

While the exact mechanism still needs to be elucidated ... How Could HIV-infected Macrophages Contribute to B-cell Lymphomas? HIV-infected macrophages may contribute to lymphomagenesis through ...

Dr. Hosoya says, "Although a few case reports of laryngeal edema with tisa-cel treatment for B-cell lymphoma have appeared, the mechanism of this phenomenon is still unknown and no established ...

B-cell lymphoma is a type of blood cancer that affects the B lymphocytes of the immune system. They usually arise in the lymph nodes or in other lymphoid tissue, such as the spleen, bone marrow ...

Diffuse large B-cell lymphoma and treatment advances for diffuse ... the signal causes the B cell to die 3. These mechanisms are shown in more detail in Figure 1. Rituximab in combination with ...

ECHELON-3 (NCT04404283) principal investigator Craig A. Portell, MD, speaks to the significance of this triplet approval from ...

During a live event, Catherine J. Lee, MD, MS, discussed the mechanism of action of approved therapies for chronic ...

DelveInsight’s, “Non-Hodgkin Lymphoma Pipeline Insight ... address adaptive immune resistance mechanisms to enhance anticancer activity against B-cell malignancies. The drug is being evaluated ...